Cybin is evaluating CYB004 in a section two medical demo focusing on generalized stress and anxiety disorder. The drugmaker expects to report topline benefits from this study in the primary half of 2025.Gummies aren’t the one psilocybin-infused edibles which can be appearing out there. Dozens of other special and impressive goods supply the user